Study Shows Medalogix Technology Significantly Reduces Death Among Home Health Patients

April 22, 2015

FOR IMMEDIATE RELEASE
Results peer-reviewed by Vanderbilt University

Nashville, Tennessee, April 22, 2015 — A study conducted by Nashville-based healthcare technology company Medalogix and peer-reviewed by Vanderbilt University shows that Medalogix’s “Bridge” technology decreases the risk of patient death in the home health care setting by 52 percent. The study also finds that Bridge reduces by 30 percent the risk of early death during hospice home care for the terminally ill.

Medalogix Bridge is a clinical support tool that assists clinicians in identifying and managing the right patients for hospice care at the right time.

According to the Dartmouth Atlas of Health Care, more than 80 percent of patients with chronic diseases want to die at home. Hospice treatment allows patients to do that, but qualified patients are often not identified quickly enough. In fact, the Centers for Disease Control, reports that only 25 percent of Americans actually die in their homes. Medalogix Bridge users, however, experience a 62 percent increase in identification of hospice-appropriate patients. Additionally, Bridge increased days spent on hospice by 21 percent.

“Observational statistics of our clients have shown the effectiveness of our Bridge technology, but having the study peer-reviewed by Vanderbilt confirms the huge impact Bridge is having on end-of-life patient care,” said Dan Hogan, CEO of Medalogix. “Our hope is that this study allows us to continue expanding our client base and scope of care.”

Further, Bridge produces significant healthcare savings. A home health agency with an average daily census of 1,600 patients could expect a three-year financial benefit of $798,554. And, if scaled to every level of the acuity ladder, Bridge could generate $2 billion in annual savings to the health care system by identifying palliative care patients earlier.

In recognition of its innovative product and potential positive impact to the US Healthcare system, Medalogix was recently selected as a finalist from a pool of 500 applicants and awarded $37,000 in Harvard University’s Health Acceleration Challenge. Hogan recently presented at the Forum on Health Innovation, along with the other finalists, to an audience of healthcare CEOs, influencers and Harvard faculty.  

 

About Medalogix

Medalogix is a Nashville-based healthcare technology company that provides analytics and workflows to home health providers so they can improve care and reduce costs. Founded in 2012 by former home health agency owner Dan Hogan, Medalogix has been recognized by Harvard University, HIMSS and Fierce Healthcare IT as an innovative solution that’s improving America’s Healthcare system. Medalogix currently offers two solutions: Touch, which automates a home health clinical team’s touchpoints, and Bridge, which helps identify and inform patients who would benefit from hospice care.

Stay Up-to-Date on the Latest News, Events and Resources!

Sign-up to receive timely industry updates, helpful articles, live and on-demand webinars, and much more – all delivered directly to your inbox.